Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Inflammatory Reliever Therapy for Asthma Using Inhaled Budesonide/Formoterol As-needed With or Without Maintenance in South African Children: A Pragmatic Open Label Phase 3 Randomised Controlled Trial

NCT06429475 is registered in ClinicalTrials.gov with University of KwaZulu as lead sponsor.

NCT NCT06429475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06429475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Inflammatory Reliever Therapy for Asthma Using Inhaled Budesonide/Formoterol As-needed With or Without Maintenance in South African Children: A Pragmatic Open Label Phase 3 Randomised Controlled Trial
Lead sponsor
University of KwaZulu
Phase
Phase 3
Overall status
Recruiting
Start date
June 6, 2024
Completion date
December 31, 2028
Enrollment
1,038 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma